divendres, 24 de febrer del 2017

MassDevice.com +5 | The top 5 medtech stories for February 24, 2017

plus5-node

Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.

Get this in your inbox everyday by subscribing to our newsletters.


5. FDA panel supports Claret Medical’s Sentinel, despite efficacy questions

MassDevice.com news

The FDA’s Circulatory System Devices Panel this week gave its support to de novo clearance for Claret Medical’s Sentinel embolic protection device despite weak efficacy data for the device. Read more


4. CEOs shouldn’t fear Trump: Ex-Medtronic chief George

MassDevice.com news

Although the administration’s promises for lower taxes, fewer regulations and improved infrastructure would be a boon to business, CEOs are leery of other pledges to impose large tariffs for imported products and decimate the immigrant labor pool. Former Medtronic (NYSE:MDT) CEO William George, writing for CNBC, said the corner office should proceed as planned in the face of Trumpian uncertainty. Read more


3. Medtronic touts Solitaire stent retriever data

MassDevice.com news

The Solitare stent retriever Medtronic (NYSE:MDT) acquired for $50 billion last year when it bought Covidien is safe and highly effective when combined with standard care using the thrombolysis drug alteplase, according to a meta-analysis of 4 previous trials of the device. Read more


2. Intersect ENT wins FDA nod for Propel Contour steroid-releasing implant

MassDevice.com news

Intersect ENT(NSDQ:XENT) said today that it won FDA approval for its Propel Contour steroid-releasing implant for the treatment of chronic sinusitis in the frontal and maxillary sinsuses. Read more


1. Medtronic lands CE Mark for quad MRI-safe pacers

MassDevice.com news

Medtronic (NYSE:MDT) said today that it won CE Mark approval in the European Union for its line of quadripolar, MRI-safe cardiac resynchronization therapy pacemakers. Read more

The post MassDevice.com +5 | The top 5 medtech stories for February 24, 2017 appeared first on MassDevice.



from MassDevice http://ift.tt/2lE1C2R

Cap comentari:

Publica un comentari a l'entrada